Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Merck RSV Drug & Pharma News – STAT+ Roundup - News Directory 3

Merck RSV Drug & Pharma News – STAT+ Roundup

June 10, 2025 Health
News Context
At a glance
  • Genetic testing firm 23andMe faces scrutiny today as founder Anne Wojcicki is set to testify before a House committee.
  • Wojcicki's appearance comes⁣ amid heightened awareness of genetic information security.
  • Separately, National institutes of Health (NIH) director Jay Bhattacharya will appear before a Senate committee.
Original source: statnews.com

Anne Wojcicki, ⁣the founder of 23andMe, is set⁣ to testify before ⁢a House committee today, with data privacy at the forefront of‍ the discussion. This hearing examines critical data privacy concerns and ⁤national security implications stemming from the company’s bankruptcy. lawmakers will question ‍Wojcicki on measures to protect consumer genetic details during the bankruptcy sale. concurrently, NIH Director Jay Bhattacharya will address Senate members regarding potential budget cuts and their impact on vital research funding. These developments underscore the increasing focus on the responsible handling of sensitive data throughout the healthcare and technology spheres. News Directory 3 keeps you informed through comprehensive reporting. Discover⁢ what’s next for 23andMe and the NIH in these timely Capitol Hill hearings.

Key Points

  • 23andMe founder Anne Wojcicki⁣ testifies before House committee.
  • Hearing addresses data privacy concerns amid bankruptcy.
  • NIH Director Jay Bhattacharya discusses budget cuts before Senate.

23andMe Data Privacy hearing on Capitol‍ Hill

Updated June 10, 2025

Genetic testing firm 23andMe faces scrutiny today as founder Anne Wojcicki is set to testify before a House committee. The hearing addresses concerns about data privacy and national security arising from the company’s bankruptcy proceedings.

Wojcicki’s appearance comes⁣ amid heightened awareness of genetic information security. Lawmakers are expected to ⁤press her on measures to protect consumer data ⁢during the bankruptcy sale.

Separately, National institutes of Health (NIH) director Jay Bhattacharya will appear before a Senate committee. He is scheduled to discuss proposed budget cuts to the agency and their potential impact on research funding.

Both hearings are expected to draw meaningful attention, with lawmakers focusing on the balance between innovation and safeguarding sensitive information.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related reading

  • US Measles Resurgence Driven by Falling Vaccination Rates and Misinformation
  • Your Weekly Horoscope: August 2-8, 2026

Related

biotechnology, drug development, drug prices, Research

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com